BRIEF SUMMARY Infectious diseases, respiratory tract infections, and specific epidemiological cases in Kosovo create periodic and permanent enormous pressure on the public healthcare system. According to Kosovo Agency of Statistics (ASK) data, the number of reported infectious disease cases across the country exceeded 219,000 in 2022. Simultaneously, Tuberculosis (TB) cases, which directly concern lung health, follow a stable course at approximately 600 per year. This heavy infection picture in regions such as Pristina, Prizren, and Malishevë — notable for endemic case increases — points to a strong and continuous market need for private pulmonology (chest disease) clinics, allergy/immunology centers, diagnostic infection laboratories, and preventive medicine (vaccination/travel health) investments.
n Tuberculosis (TB) disease still continues to exist in Kosovo with an average of 600 new cases every year (615 in 2022, 585 cases in 2023). When tuberculosis treatment, lung sensitivities developing after Covid-19 and increasing asthma/allergy cases come together; The branch of "Pulmonology (Chest Diseases)" has become one of the most sought-after specializations in Kosovo. Private clinics offering Respiratory Function Test (PFT), bronchoscopy and allergy panels are an extremely profitable investment alternative for patients who want to escape from the busyness of public hospitals.
As the t Venture team, our analysis is that the awareness of "taking precautions before getting sick" (Preventive Medicine) is rapidly spreading in the middle and upper income groups of Kosovo. Boutique polyclinics that offer special vaccination applications and immune-boosting serum treatments provide rapid returns (ROI) with low capital. However, it is a legal obligation for companies that will operate in this field to strictly comply with the Kosovo Medical Products Agency (AKPPM) rules and cold chain transportation certifications when importing vaccines and medical kits.